Literature DB >> 27609799

Change in plasma volume and prognosis in acute decompensated heart failure: an observational cohort study.

Sarah R Hudson1, Daniel Chan1, Leong L Ng2.   

Abstract

OBJECTIVES: This study aimed to develop an inexpensive, readily available prognostic indicator in acute decompensated heart failure patients to guide management and improve outcome. Prognostic biomarkers for heart failure exist but are expensive and not routinely performed. Increasing plasma volume has been associated with worse outcomes.
SETTING: UK University Teaching Hospital.
DESIGN: Observational Cohort study. PARTICIPANTS: 967 patients with acute decompensated heart failure.
METHODS: Haemoglobin and haematocrit were measured at admission and discharge and were used to calculate the plasma volume change using the Strauss-Davis-Rosenbaum formula. MAIN OUTCOME MEASURES: Endpoints were death and the composite of death and/or heart failure hospitalisation. Change in plasma volume was added to ADHERE scoring to determine predictive value.
RESULTS: During follow-up, 536 died and 626 died or were hospitalised with heart failure. Multivariable Cox models showed change in plasma volume was an independent predictor of mortality (hazard ratio (HR) [95% confidence interval (CI)]: 1.150 [1.031-1.283], p = 0.012) and death or heart failure hospitalisation (HR: 1.138 [1.029-1.259], p = 0.012). Kaplan-Meier analysis of change in plasma volume tertiles for outcome measures showed significant difference for the top tertile compared to the lower two. Multivariable analysis of change in plasma volume with ADHERE scoring showed change in plasma volume change remained an independent predictor of death (HR: 1.138 [1.026-1.261], p = 0.015) and death or heart failure hospitalisation (HR: 1.129 [1.025-1.243], p = 0.014).
CONCLUSIONS: Change in plasma volume over an admission can be used for prognostication and adds value to the ADHERE score. Change in plasma volume can be easily and inexpensively calculated from routine blood tests. Clinically, this may facilitate targeted treatment of acute decompensated heart failure patients at greatest risk. © The Royal Society of Medicine.

Entities:  

Keywords:  Plasma volume; acute heart failure; haematocrit; haemoglobin

Mesh：

Substances：

Year:  2016        PMID： 27609799      PMCID： PMC5017520          DOI： 10.1177/0141076816661316

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


  22 in total

1.  Clinical correlates of hemoconcentration during hospitalization for acute decompensated heart failure.

Authors:  Carlos Davila; Alex Reyentovich; Stuart D Katz
Journal:  J Card Fail       Date:  2011-09-03       Impact factor: 5.712

2.  Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.

Authors:  Cynthia Binanay; Robert M Califf; Vic Hasselblad; Christopher M O'Connor; Monica R Shah; George Sopko; Lynne W Stevenson; Gary S Francis; Carl V Leier; Leslie W Miller
Journal:  JAMA       Date:  2005-10-05       Impact factor: 56.272

3.  The limited reliability of physical signs for estimating hemodynamics in chronic heart failure.

Authors:  L W Stevenson; J K Perloff
Journal:  JAMA       Date:  1989-02-10       Impact factor: 56.272

4.  Terminology and definition of changes renal function in heart failure.

Authors:  Kevin Damman; W H Wilson Tang; Jeffrey M Testani; John J V McMurray
Journal:  Eur Heart J       Date:  2014-08-24       Impact factor: 29.983

5.  The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

Authors:  D L Dries; D V Exner; M J Domanski; B Greenberg; L W Stevenson
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

6.  Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis.

Authors:  Gregg C Fonarow; Kirkwood F Adams; William T Abraham; Clyde W Yancy; W John Boscardin
Journal:  JAMA       Date:  2005-02-02       Impact factor: 56.272

7.  The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

Authors:  James L Januzzi; Carlos A Camargo; Saif Anwaruddin; Aaron L Baggish; Annabel A Chen; Daniel G Krauser; Roderick Tung; Renee Cameron; J Tobias Nagurney; Claudia U Chae; Donald M Lloyd-Jones; David F Brown; Stacy Foran-Melanson; Patrick M Sluss; Elizabeth Lee-Lewandrowski; Kent B Lewandrowski
Journal:  Am J Cardiol       Date:  2005-04-15       Impact factor: 2.778

8.  Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractions.

Authors:  Dmitry Abramov; Rose S Cohen; Stuart D Katz; Donna Mancini; Mathew S Maurer
Journal:  Am J Cardiol       Date:  2008-07-31       Impact factor: 2.778

Review 9.  The prognostic value of the physical examination in patients with chronic heart failure.

Authors:  J Eduardo Rame; Daniel L Dries; Mark H Drazner
Journal:  Congest Heart Fail       Date:  2003 May-Jun

10.  Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.

Authors:  Stephen J Greene; Mihai Gheorghiade; Muthiah Vaduganathan; Andrew P Ambrosy; Robert J Mentz; Haris Subacius; Aldo P Maggioni; Savina Nodari; Marvin A Konstam; Javed Butler; Gerasimos Filippatos
Journal:  Eur J Heart Fail       Date:  2013-07-11       Impact factor: 15.534
View more
  8 in total

1.  Diagnostic and prognostic value of plasma volume status at emergency department admission in dyspneic patients: results from the PARADISE cohort.

Authors:  Tahar Chouihed; Patrick Rossignol; Adrien Bassand; Kévin Duarte; Masatake Kobayashi; Déborah Jaeger; Sonia Sadoune; Aurélien Buessler; Lionel Nace; Gaetan Giacomin; Thibaut Hutter; Françoise Barbé; Sylvain Salignac; Nicolas Jay; Faiez Zannad; Nicolas Girerd
Journal:  Clin Res Cardiol       Date:  2018-10-28       Impact factor: 5.460

2.  Calculated Estimates of Plasma Volume in Patients With Chronic Heart Failure-Comparison With Measured Volumes.

Authors:  Marat Fudim; Wayne L Miller
Journal:  J Card Fail       Date:  2018-08-08       Impact factor: 5.712

3.  Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF).

Authors:  Marat Fudim; Kishan S Parikh; Allison Dunning; Adam D DeVore; Robert J Mentz; Phillip J Schulte; Paul W Armstrong; Justin A Ezekowitz; W H Wilson Tang; John J V McMurray; Adriaan A Voors; Mark H Drazner; Christopher M O'Connor; Adrian F Hernandez; Chetan B Patel
Journal:  Am J Cardiol       Date:  2018-08-03       Impact factor: 2.778

Review 4.  Estimated plasma volume status in heart failure: clinical implications and future directions.

Authors:  Masatake Kobayashi; Nicolas Girerd; Kevin Duarte; Tahar Chouihed; Taishiro Chikamori; Bertram Pitt; Faiez Zannad; Patrick Rossignol
Journal:  Clin Res Cardiol       Date:  2021-01-06       Impact factor: 5.460

5.  Empagliflozin's Ameliorating Effect on Plasma Triglycerides: Association with Endothelial Function Recovery in Diabetic Patients with Coronary Artery Disease.

Authors:  Takahiro Sawada; Kenzo Uzu; Naoko Hashimoto; Tetsuari Onishi; Tomofumi Takaya; Akira Shimane; Yasuyo Taniguchi; Yoshinori Yasaka; Takeshi Ohara; Hiroya Kawai
Journal:  J Atheroscler Thromb       Date:  2019-10-18       Impact factor: 4.928

6.  Discordance between estimated and measured changes in plasma volume among patients with acute heart failure.

Authors:  Jutta S Swolinsky; Enkhtuvshin Tuvshinbat; David M Leistner; Frank Edelmann; Fabian Knebel; Niklas P Nerger; Caroline Lemke; Robert Roehle; Michael Haase; Maria Rosa Costanzo; Geraldine Rauch; Veselin Mitrovic; Edis Gasanin; Daniel Meier; Peter A McCullough; Kai-Uwe Eckardt; Bruce A Molitoris; Kai M Schmidt-Ott
Journal:  ESC Heart Fail       Date:  2021-12-08

7.  Plasma Volume and Renal Function Predict Six-Month Survival after Hospitalization for Acute Decompensated Heart Failure.

Authors:  Kenneth C Bilchick; Nathaniel Chishinga; Alex M Parker; David X Zhuo; Mitchell H Rosner; LaVone A Smith; Hunter Mwansa; Jacob N Blackwell; Peter A McCullough; Sula Mazimba
Journal:  Cardiorenal Med       Date:  2017-11-03       Impact factor: 2.041

8.  Sex Differences in the Evaluation of Congestion Markers in Patients with Acute Heart Failure.

Authors:  Pietro Scicchitano; Claudio Paolillo; Micaela De Palo; Angela Potenza; Silvia Abruzzese; Marco Basile; Antonia Cannito; Maria Tangorra; Piero Guida; Pasquale Caldarola; Marco Matteo Ciccone; Francesco Massari
Journal:  J Cardiovasc Dev Dis       Date:  2022-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.